Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Early Phase 1:1
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Early Phase 1
1 (50.0%)Phase 1
1 (50.0%)Study of OB-002 in Patients With Refractory Metastatic Cancer
Phase 1
Withdrawn
- Conditions
- Metastatic CancerMetastatic Urothelial CarcinomaMetastatic Colorectal CancerMetastatic Pancreatic CancerMetastatic Gastric CancerMetastatic Breast Cancer
- Interventions
- First Posted Date
- 2023-07-11
- Last Posted Date
- 2025-04-09
- Lead Sponsor
- Orion Biotechnology Polska Sp. z o.o.
- Target Recruit Count
- 36
- Registration Number
- NCT05940844
OB-002H Gel Administered Vaginally and Rectally in HIV-1 Seronegative Adults
- First Posted Date
- 2021-03-10
- Last Posted Date
- 2021-03-18
- Lead Sponsor
- Orion Biotechnology Polska Sp. z o.o.
- Target Recruit Count
- 60
- Registration Number
- NCT04791007
- Locations
- 🇵🇱
BioVirtus Centrum Medyczne Sp. z o.o., Józefów, Poland
News
No news found